ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2024

Continuation of immunotherapy beyond progression is beneficial to the survival of advanced non-small-cell lung cancer.

Yuanyuan Cheng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.